Vincent Muller
Physician Assistant · Belen, NMNPI 1053412692
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$343
- Sanofi-aventis U.S. LLC$269
- Nestle Healthcare Nutrition Inc.$224
- AstraZeneca$219
- AbbVie$216
- Lilly USA, LLC$205
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,88799%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $343 |
| Sanofi-aventis U.S. LLC | 16 | $269 |
| Nestle Healthcare Nutrition Inc. | 13 | $224 |
| AstraZeneca | 13 | $219 |
| AbbVie | 11 | $216 |
| Lilly USA, LLC | 11 | $205 |
| Otsuka America Pharmaceutical, Inc. | 10 | $203 |
| Novo Nordisk | 12 | $173 |
| Mylan Specialty L.p. | 4 | $107 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $98 |
| Aimmune Therapeutics, Inc. | 5 | $94 |
| Amgen | 4 | $87 |
| Bayer | 4 | $68 |
| GSK | 4 | $64 |
| Astellas Pharma US Inc | 2 | $61 |
| Pfizer | 3 | $56 |
| Exact Sciences | 3 | $48 |
| Boehringer Ingelheim | 2 | $46 |
| Novartis | 2 | $41 |
| Dexcom, Inc. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Amarin Pharma, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $28 |
| Nevro Corp. | 1 | $23 |
| Merck | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$2,903 in reported general payments places this provider in the 90th percentile of 635 physician assistant providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $24,490 |
| JardianceEmpagliflozin | 23 | $24,380 |
| JanuviaSitagliptin Phosphate | 24 | $19,387 |
| XareltoRivaroxaban | 16 | $15,347 |
| OzempicSemaglutide | 14 | $13,660 |
| FarxigaDapagliflozin Propanediol | 13 | $11,235 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 182 | $4,576 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 145 | $3,764 |
| Gabapentin | 215 | $3,725 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $2,923 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 58 | $2,331 |
| Atorvastatin Calcium | 164 | $2,033 |
| Ibuprofen | 159 | $2,013 |
| Pantoprazole Sodium | 199 | $1,926 |
| Omeprazole | 171 | $1,818 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $56 | $24,49031 claims |
| Boehringer IngelheimJardiance | $46 | $24,38023 claims |
| MerckJanuvia | $20 | $19,38724 claims |
| Johnson & JohnsonXarelto | $13 | $15,34716 claims |
| Novo NordiskOzempic | $173 | $13,66014 claims |
| AstraZenecaFarxiga | $219 | $11,23513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 635 physician assistant providers in New Mexico.
Other physician assistant in Belen
- Erin RayburnSanta Fe$25K
- Leigh HigginsAlbuquerque$10K
- Maria AbeytaAlbuquerque$8K
- Kari LavigneAlbuquerque$8K
- Elizabeth BelitzAlbuquerque$8K
- Laura OnoratoSanta Fe$7K
- Eric GriffinFarmington$6K
- Desiree BarelaAlbuquerque$6K
- Stephanie BeyesAlbuquerque$5K
- Stephanie GonzalesAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.